CHITOGEN INC
PLYMOUTH, MN · CIK 0001470264 · Medtech · Private
Chitosan fiber hemostatic pad for accelerating blood clot formation
chitogen.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $347K
- 5 Form D · Dec 2023
- 34 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $105,000 | |
| Private capital raised | Form D · SEC | $35,000 | |
| Private capital raised | Form D · SEC | $207,000 | |
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $1,050,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 983 | ICHOR VASCULAR INC. | — | $3.1M |
| 984 | SPEECHVIVE, INC. | — | $280K |
| 985 | VIVAQUANT, LLC | — | $175K |
| 986 | CHITOGEN INC | — | $347K |
| 987 | Happy Cloud, Inc. | — | $4.5M |
| 988 | ISOMARK, LLC | — | $262K |
| 989 | Plasmology4, Inc. | — | $5.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Frederick AlbrightDirector
- James DrakeDirector · Executive Officer
- Douglas EayrsDirector · Executive Officer
- Albert EmolaDirector · Executive Officer
- Kai KrollDirector · Executive Officer
- Robert LevyDirector
- Steve MuellerleileExecutive Officer
- Michael ReillyDirector · Executive Officer
- Thomas RitterExecutive Officer
- Donald SturtevantDirector
- Yong ZhuDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.